{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:57:50Z","timestamp":1790895470059,"version":"4.1.0"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.2215\/cjn.00860115","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T23:56:22Z","timestamp":1428710182000},"page":"1291-1299","source":"Crossref","is-referenced-by-count":102,"title":["Drug-Induced Glomerular Disease"],"prefix":"10.2215","volume":"10","author":[{"given":"Glen S.","family":"Markowitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Bomback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20230601","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Viral interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"R2-24-20230601","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-alpha, -beta, or -gamma is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-24-20230601","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0002-9378(86)90844-6","article-title":"Tubuloreticular inclusions in placental chorionic villi of rhesus monkeys after maternal treatment with interferon","volume":"155","author":"Feldman","year":"1986","journal-title":"Am J Obstet Gynecol"},{"key":"R4-24-20230601","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R5-24-20230601","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/ki.2014.270","article-title":"Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1","volume":"87","author":"Nichols","year":"2015","journal-title":"Kidney Int"},{"key":"R6-24-20230601","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","article-title":"Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate","volume":"12","author":"Markowitz","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R7-24-20230601","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/ki.2008.356","article-title":"Bisphosphonate nephrotoxicity","volume":"74","author":"Perazella","year":"2008","journal-title":"Kidney Int"},{"key":"R8-24-20230601","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1523-1755.2003.00071.x","article-title":"Toxic acute tubular necrosis following treatment with zoledronate (Zometa)","volume":"64","author":"Markowitz","year":"2003","journal-title":"Kidney Int"},{"key":"R9-24-20230601","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1053\/ajkd.2002.32797","article-title":"Nephrotic syndrome after treatment with pamidronate","volume":"39","author":"Markowitz","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R10-24-20230601","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1523-1755.2004.00426.x","article-title":"Podocyte injury associated glomerulopathies induced by pamidronate","volume":"65","author":"Barri","year":"2004","journal-title":"Kidney Int"},{"key":"R11-24-20230601","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1093\/ndt\/gfm209","article-title":"Focal segmental glomerulosclerosis associated with long-term treatment with zoledronate in a myeloma patient","volume":"22","author":"Bodmer","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"R12-24-20230601","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000366450","article-title":"Collapsing focal segmental glomerulosclerosis resulting from a single dose of zoledronate","volume":"4","author":"Neyra","year":"2014","journal-title":"Nephron Extra"},{"key":"R13-24-20230601","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00198-007-0361-9","article-title":"Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate","volume":"18","author":"Pascual","year":"2007","journal-title":"Osteoporos Int"},{"key":"R14-24-20230601","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/pgmj.49.570.277","article-title":"Acute renal failure and lithium intoxication","volume":"49","author":"Lavender","year":"1973","journal-title":"Postgrad Med J"},{"key":"R15-24-20230601","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ki.1977.102","article-title":"Chronic renal lesions following long-term treatment with lithium","volume":"12","author":"Hestbech","year":"1977","journal-title":"Kidney Int"},{"key":"R16-24-20230601","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1681\/ASN.V1181439","article-title":"Lithium nephrotoxicity: A progressive combined glomerular and tubulointerstitial nephropathy","volume":"11","author":"Markowitz","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"R17-24-20230601","doi-asserted-by":"crossref","first-page":"70","DOI":"10.7326\/0003-4819-92-1-70","article-title":"Minimal-change disease and the nephrotic syndrome associated with lithium therapy","volume":"92","author":"Richman","year":"1980","journal-title":"Ann Intern Med"},{"key":"R18-24-20230601","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1176\/ajp.146.1.84","article-title":"Lithium-induced nephrotic syndrome","volume":"146","author":"Wood","year":"1989","journal-title":"Am J Psychiatry"},{"key":"R19-24-20230601","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0272-6386(96)90108-0","article-title":"Nephrotic syndrome and renal insufficiency associated with lithium therapy","volume":"27","author":"Tam","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R20-24-20230601","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/0002-9343(88)90077-0","article-title":"Focal segmental glomerulosclerosis in patients receiving lithium carbonate","volume":"84","author":"Santella","year":"1988","journal-title":"Am J Med"},{"key":"R21-24-20230601","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s00467-001-0809-7","article-title":"Lithium-induced nephrotic syndrome in a young pediatric patient","volume":"17","author":"Sakarcan","year":"2002","journal-title":"Pediatr Nephrol"},{"key":"R22-24-20230601","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJM197912063012306","article-title":"Reversible renal failure and nephrotic syndrome associated with nonsteroidal anti-inflammatory drugs","volume":"301","author":"Brezin","year":"1979","journal-title":"N Engl J Med"},{"key":"R23-24-20230601","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000183239","article-title":"Nephrotic syndrome associated with use of the nonsteroidal anti-inflammatory drugs. Case report and review of the literature","volume":"37","author":"Feinfeld","year":"1984","journal-title":"Nephron"},{"key":"R24-24-20230601","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000413416","article-title":"Renal toxicity of nonsteroidal anti-inflammatory drugs","volume":"55","author":"Pirani","year":"1987","journal-title":"Contrib Nephrol"},{"key":"R25-24-20230601","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1053\/ajkd.2002.36349","article-title":"Nephrotic syndrome and interstitial nephritis associated with celecoxib","volume":"40","author":"Alper","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R26-24-20230601","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1111\/ajt.12852","article-title":"Risk of metabolic complications in kidney transplantation after conversion to mTOR inhibitor: A systematic review and meta-analysis","volume":"14","author":"Murakami","year":"2014","journal-title":"Am J Transplant"},{"key":"R27-24-20230601","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2215\/CJN.03751106","article-title":"High sirolimus levels may induce focal segmental glomerulosclerosis de novo","volume":"2","author":"Letavernier","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R28-24-20230601","doi-asserted-by":"crossref","first-page":"e80340","DOI":"10.1371\/journal.pone.0080340","article-title":"Cellular effects of everolimus and sirolimus on podocytes","volume":"8","author":"M\u00fcller-Krebs","year":"2013","journal-title":"PLoS ONE"},{"key":"R29-24-20230601","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.ajkd.2008.12.024","article-title":"Rapamycin for focal segmental glomerulosclerosis: A report of 3 cases","volume":"54","author":"Tsagalis","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R30-24-20230601","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1681\/ASN.2009040450","article-title":"Development of focal segmental glomerulosclerosis after anabolic steroid abuse","volume":"21","author":"Herlitz","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R31-24-20230601","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJMra1312353","article-title":"Syndromes of thrombotic microangiopathy","volume":"371","author":"George","year":"2014","journal-title":"N Engl J Med"},{"key":"R32-24-20230601","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.autrev.2014.01.004","article-title":"Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: Diagnosis and classification","volume":"13","author":"Shenkman","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R33-24-20230601","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.amjmed.2008.11.025","article-title":"Renal effects of anti-angiogenesis therapy: Update for the internist","volume":"122","author":"Gurevich","year":"2009","journal-title":"Am J Med"},{"key":"R34-24-20230601","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1681\/ASN.2005080810","article-title":"Vascular endothelial growth factor a signaling in the podocyte-endothelial compartment is required for mesangial cell migration and survival","volume":"17","author":"Eremina","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R35-24-20230601","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000101798","article-title":"Role of the VEGF\u2014a signaling pathway in the glomerulus: Evidence for crosstalk between components of the glomerular filtration barrier","volume":"106","author":"Eremina","year":"2007","journal-title":"Nephron Physiol"},{"key":"R36-24-20230601","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1056\/NEJMoa0707330","article-title":"VEGF inhibition and renal thrombotic microangiopathy","volume":"358","author":"Eremina","year":"2008","journal-title":"N Engl J Med"},{"key":"R37-24-20230601","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/annonc\/mdn713","article-title":"Management of hypertension in angiogenesis inhibitor-treated patients","volume":"20","author":"Izzedine","year":"2009","journal-title":"Ann Oncol"},{"key":"R38-24-20230601","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejca.2009.11.001","article-title":"VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management","volume":"46","author":"Izzedine","year":"2010","journal-title":"Eur J Cancer"},{"key":"R39-24-20230601","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.ajkd.2006.11.039","article-title":"Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: Systematic review and meta-analysis","volume":"49","author":"Zhu","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"R40-24-20230601","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/02841860802314720","article-title":"Risk of hypertension and renal dysfunction with an angiogenesis inhibitor sunitinib: Systematic review and meta-analysis","volume":"48","author":"Zhu","year":"2009","journal-title":"Acta Oncol"},{"key":"R41-24-20230601","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/MD.0000000000000207","article-title":"Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): An 8-year observational study at a single center","volume":"93","author":"Izzedine","year":"2014","journal-title":"Medicine (Baltimore"},{"key":"R42-24-20230601","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ki.2013.344","article-title":"Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy","volume":"85","author":"Izzedine","year":"2014","journal-title":"Kidney Int"},{"key":"R43-24-20230601","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/ndt\/gfl507","article-title":"Gemcitabine-induced thrombotic microangiopathy: A systematic review","volume":"21","author":"Izzedine","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R44-24-20230601","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/jnci\/djr128","article-title":"Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib","volume":"103","author":"Rini","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"R45-24-20230601","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ndt\/gfn657","article-title":"Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib","volume":"24","author":"Boll\u00e9e","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R46-24-20230601","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1055\/s-2005-925474","article-title":"Drug-induced thrombotic microangiopathy","volume":"31","author":"Zakarija","year":"2005","journal-title":"Semin Thromb Hemost"},{"key":"R47-24-20230601","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1200\/JCO.1989.7.6.781","article-title":"Cancer-associated hemolytic-uremic syndrome: Analysis of 85 cases from a national registry","volume":"7","author":"Lesesne","year":"1989","journal-title":"J Clin Oncol"},{"key":"R48-24-20230601","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1002\/cncr.20290","article-title":"Gemcitabine-associated thrombotic microangiopathy","volume":"100","author":"Humphreys","year":"2004","journal-title":"Cancer"},{"key":"R49-24-20230601","doi-asserted-by":"crossref","first-page":"130","DOI":"10.5414\/CNP71130","article-title":"Gemcitabine nephrotoxicity and hemolytic uremic syndrome: Report of 29 cases from a single institution","volume":"71","author":"Glezerman","year":"2009","journal-title":"Clin Nephrol"},{"key":"R50-24-20230601","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00005792-200207000-00008","article-title":"Alpha-interferon-associated thrombotic microangiopathy: A clinicopathologic study of 8 patients and review of the literature","volume":"81","author":"Zuber","year":"2002","journal-title":"Medicine (Baltimore"},{"key":"R51-24-20230601","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJMc1316118","article-title":"Thrombotic microangiopathy associated with interferon beta","volume":"370","author":"Hunt","year":"2014","journal-title":"N Engl J Med"},{"key":"R52-24-20230601","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/00365520600930685","article-title":"Thrombotic thrombocytopenic purpura with fatal outcome in a patient with chronic hepatitis C treated with pegylated interferon-a\/2b","volume":"42","author":"Deutsch","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"R53-24-20230601","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.gcb.2007.12.019","article-title":"Thrombotic thrombocytopenic purpura complicating interferon therapy in chronic C hepatitis","volume":"32","author":"Sall\u00e9e","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"key":"R54-24-20230601","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11255-013-0401-7","article-title":"Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis","volume":"46","author":"Orvain","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"R55-24-20230601","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1055\/s-0032-1328894","article-title":"Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: A 20-year review from the Southern Network on Adverse Reactions (SONAR)","volume":"38","author":"Jacob","year":"2012","journal-title":"Semin Thromb Hemost"},{"key":"R56-24-20230601","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2008.613","article-title":"Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): Review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008)","volume":"112","author":"Zakarija","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"R57-24-20230601","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1182\/blood-2013-03-487694","article-title":"Complement factor H mutations are present in ADAMTS13-deficient, ticlopidine-associated thrombotic microangiopathies","volume":"121","author":"Chapin","year":"2013","journal-title":"Blood"},{"key":"R58-24-20230601","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.7326\/0003-4819-135-12-200112180-00008","article-title":"Quinine-associated thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Frequency, clinical features, and long-term outcomes","volume":"135","author":"Kojouri","year":"2001","journal-title":"Ann Intern Med"},{"key":"R59-24-20230601","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jca.20194","article-title":"Is it quinine TTP\/HUS or quinine TMA? ADAMTS13 levels and implications for therapy","volume":"24","author":"Park","year":"2009","journal-title":"J Clin Apher"},{"key":"R60-24-20230601","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0272-6386(99)70269-6","article-title":"Quinine-induced immune thrombocytopenic purpura followed by hemolytic uremic syndrome","volume":"33","author":"Glynne","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R61-24-20230601","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0002-9343(75)90353-8","article-title":"Diabetic glomerulosclerosis without glucose intolerance","volume":"59","author":"Nash","year":"1975","journal-title":"Am J Med"},{"key":"R62-24-20230601","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/00007611-198812000-00027","article-title":"Diabetic glomerulosclerosis without concurrent diabetes mellitus","volume":"81","author":"Mactier","year":"1988","journal-title":"South Med J"},{"key":"R63-24-20230601","first-page":"68","article-title":"Idiopathic lobular glomerulonephritis (nodular mesangial sclerosis): A distinct diagnostic entity","volume":"32","author":"Alpers","year":"1989","journal-title":"Clin Nephrol"},{"key":"R64-24-20230601","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/S0272-6386(99)70086-7","article-title":"Idiopathic nodular glomerulosclerosis","volume":"34","author":"Herzenberg","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R65-24-20230601","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1093\/ndt\/gfl422","article-title":"Idiopathic nodular glomerulosclerosis in a non-diabetic hypertensive smoker\u2014case report and review of literature","volume":"21","author":"Kuppachi","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R66-24-20230601","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1053\/hupa.2002.126189","article-title":"Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking","volume":"33","author":"Markowitz","year":"2002","journal-title":"Hum Pathol"},{"key":"R67-24-20230601","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.humpath.2008.05.004","article-title":"Idiopathic nodular glomerulosclerosis: A clinicopathologic study of 15 cases","volume":"39","author":"Li","year":"2008","journal-title":"Hum Pathol"},{"key":"R68-24-20230601","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1681\/ASN.2006121328","article-title":"Nodular glomerulosclerosis in the nondiabetic smoker","volume":"18","author":"Nasr","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R69-24-20230601","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ki.1995.274","article-title":"PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products","volume":"48","author":"Throckmorton","year":"1995","journal-title":"Kidney Int"},{"key":"R70-24-20230601","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.94.25.13915","article-title":"Tobacco smoke is a source of toxic reactive glycation products","volume":"94","author":"Cerami","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"R71-24-20230601","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/BF03401759","article-title":"Increased levels of advanced glycation endproducts in the lenses and blood vessels of cigarette smokers","volume":"4","author":"Nicholl","year":"1998","journal-title":"Mol Med"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201507000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:16Z","timestamp":1786369516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201507000-00024"}},"subtitle":["Direct Cellular Injury"],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":71,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.00860115","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}